Literature DB >> 29719823

Mycetomas: The Experience of the Dermatology Unit of the University of Milan.

Gianluca Nazzaro1, Stefano Veraldi1.   

Abstract

Entities:  

Keywords:  Actinomycetoma; Dermatopathology; Epidemiology; Eumycetoma; Mycetoma; Tropical disease

Year:  2018        PMID: 29719823      PMCID: PMC5920953          DOI: 10.1159/000486236

Source DB:  PubMed          Journal:  Dermatopathology (Basel)        ISSN: 2296-3529


× No keyword cloud information.
In the period from 1984 to 2016, we observed 16 patients in whom a clinical diagnosis of mycetoma was made. In 8 patients (6 males and 2 females, with an age ranging from 6 to 59 years [mean age: 37.1 years]), this diagnosis was confirmed by histopathological, mycological, and bacteriological examinations. In 2 patients, it was possible to perform polymerase chain reaction (PCR). The histopathological picture was superimposable in all patients. It showed suppurative granulomas surrounding characteristic grains in the deep dermis and subcutis (Fig. 1). In particular, granulomas were composed of neutrophils, histiocytes, and lymphocytes. In actinomycetomas, thin filamentous bacteria were present (Fig. 2); in eumycetomas, eosinophilic structures containing hyphae and spores were observed (Fig. 3). Complete patients' characteristics and etiological agents are reported in Table 1. In 2 cases, the infection was acquired in India, in 2 in Ethiopia, an in 1 case each in Senegal, Tanzania, Honduras, and Italy. Etiological agents were identified in 6 patients: Actinomadura madurae and Madurella mycetomatis in 2 patients; Aspergillus nidulans and Phialophora verrucosa in 1 patient; in 2 cases the infection was caused by Acremonium spp. and Fusarium spp. In 5 patients, mycetoma involved the foot; the buttocks, thigh, and ankle were involved in 1 patient each.
Fig. 1

A deep dermal suppurative granuloma. HE. ×100.

Fig. 2

Mixed infiltrate composed of histiocytes, giant cells, and lymphocytes surrounding bacteria in a case of actinomycetoma. HE. ×400.

Fig. 3

A case of eumycetoma: inflammatory cells surrounding eosinophilic structures containing hyphae and spores. HE. ×200.

Table 1

Patients’ characteristics and etiological agents

SexAge, yearsLocationEtiological agent
F36dorsum of the left footMadurella mycetomatis
F47plantar surface of the left footMadurella mycetomatis
M43left ankleActinomadura madurae
M39plantar surface of the right footPhialophora verrucosa
M6right thighFusarium spp.
M33left buttockAcremonium spp.
M59left footAspergillus nidulans
M34plantar surface of the right footActinomadura madurae
Mycetomas are chronic and deep infections of the skin caused by bacteria (actinomycotic mycetomas or actinomycetomas) [1,2] or fungi (eumycotic mycetomas or eumycetomas) [1,3]. The latter are observed mainly in Sub-Saharan Africa, whereas actinomycotic mycetomas occur in Central and South America. Eumycotic mycetomas are caused by phaeohyphomycetes (Exophiala spp., Madurella spp.) or hialohyphomycetes (Acremonium spp., Aspergillus spp., Fusarium spp., Pseudallescheria spp.) [4]. Etiological agents penetrate the skin through breaks caused by thorns, shrubs, and wood splinters: mycetoma is considered an occupational disease in farmers and lumberjacks. Latency time may be very long (months, years). Mycetomas are characterized clinically by the slow appearance of mildly inflammatory papules, nodules, and plaques. With time, abscesses, fistulae, and ulcers appear, with a serous-purulent discharge containing “grains” (i.e., colonies of the involved species). White or yellow grains are typical of A. madurae, A. nidulans [4], and Pseudallescheria boydii; red grains are typical of Actinomadura pelletieri; black grains of Aspergillus terreus, Exophiala jeanselmei, and M. mycetomatis. Superinfections by Staphylococcus aureus, gram-negative bacteria, and anaerobes are frequent. Mycetomas are usually located on the legs, ankles, and feet (“Madura foot”); the buttocks and thighs may be also involved. The involvement of muscles, aponeuroses, ligaments, tendons, joints, and bones is rather common. Local symptoms are usually mild, except for difficulty walking. The clinical course is chronic-relapsing [1]. The diagnosis of mycetoma is based on medical history, clinical picture, histopathological examination, mycological and bacteriological cultures, and PCR. The use of X-rays, ultrasonography, and computed tomography scan is necessary in order to evaluate the involvement of deep tissues. The therapy of eumycotic mycetomas is difficult and very long [5]. Several systemic antimycotics, such as fluconazole, itraconazole, ketoconazole, posaconazole, voriconazole, and terbinafine, have been used. The association itraconazole-terbinafine seems to be more effective than itraconazole alone and terbinafine alone. Isavuconazole is a promising drug. Surgery is necessary in most of the patients.

Statement of Ethics

The authors have no ethical conflict to disclose.

Disclosure Statement

The authors have no conflicts of interest to disclose.
  5 in total

Review 1.  Eumycetoma and actinomycetoma--an update on causative agents, epidemiology, pathogenesis, diagnostics and therapy.

Authors:  P Nenoff; W W J van de Sande; A H Fahal; D Reinel; H Schöfer
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-02-27       Impact factor: 6.166

2.  Mycetoma Caused by Aspergillus nidulans.

Authors:  Stefano Veraldi; Anna Grancini; Luigia Venegoni; Valentina Merlo; Elena Guanziroli; Claudia Menicanit; Gianluca Nazzaro; Annamaria Tortorano
Journal:  Acta Derm Venereol       Date:  2016-01       Impact factor: 4.437

Review 3.  Actinomycetoma: an update on diagnosis and treatment.

Authors:  Roberto Arenas; Ramón F Fernandez Martinez; Edoardo Torres-Guerrero; Carlos Garcia
Journal:  Cutis       Date:  2017-02

Review 4.  Fusarium species causing eumycetoma: Report of two cases and comprehensive review of the literature.

Authors:  Abdullah M S Al-Hatmi; Alexandro Bonifaz; Andrés Tirado-Sánchez; Jacques F Meis; G Sybren de Hoog; Sarah A Ahmed
Journal:  Mycoses       Date:  2016-12-07       Impact factor: 4.377

Review 5.  Managing mycetomas.

Authors:  Mahreen Ameen
Journal:  Trop Doct       Date:  2009-04       Impact factor: 0.731

  5 in total
  2 in total

1.  Eumycetoma of the Foot due to Fusarium solani in a Person with Diabetes Mellitus: Report of a Case and Review of Literature.

Authors:  Liza Das; Divya Dahiya; Kirti Gupta; Mahesh Prakash; Bhanu Malhotra; Ashu Rastogi; Hansraj Choudhary; Shivaprakash M Rudramurthy; Pinaki Dutta
Journal:  Mycopathologia       Date:  2021-03-09       Impact factor: 2.574

Review 2.  Mycetoma: a clinical dilemma in resource limited settings.

Authors:  Pembi Emmanuel; Shyam Prakash Dumre; Stephen John; Juntra Karbwang; Kenji Hirayama
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-08-10       Impact factor: 3.944

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.